Tubercolosis resistente a multiples medicamentos
Tubercolosis resistente a multiples medicamentos
Barra lateral del artículo
PDF
FLIP
Contenido principal del artículo
Resumen
Introducción: la tuberculosis (TB) pulmonar es un problema creciente de salud mundial y la resistencia a los antibióticos un elemento de preocupación.
Caso clínico: paciente de 19 años, quien ingresó al servicio de urgencias por presentar hemoptisis. Antecedente de TB con tratamiento irregular. Se documentó resistencia a varios medicamentos. Se consideraron las diferentes estrategias de tratamiento disponible. Debido al elevado riesgo epidemiológico y la historia de pobre adherencia al tratamiento, se realizó manejo intrahospitalario con respuesta satisfactoria.
Conclusiones: la tuberculosis multirresistente (MDR-TB) representa un riesgo para la comunidad, teniendo en cuenta la vía de transmisión de la entidad. Rev.cienc. biomed. 2013;4(1):159-164
Palabras clave:
Descargas
Detalles del artículo
Referencias (VER)
The Lancet Infectious D. The worldwide epidemic of multidrug-resistant tuberculosis. The Lancet infectious diseases. 2011; 11(5): 333.
Hafkin J, Modongo C, Newcomb C, Lowenthal E, MacGregor RR, Steenhoff AP, et al. Impact of the human immunodeficiency virus on early multidrug-resistant tuberculosis treatment outcomes in Botswana. Int J Tuberc Disease. 2013;17(3):348-353.
Spigelman M, Compton C, Gheuens J. Multidrug-resistant tuberculosis. The NEngl J Med. 2012;367(22):2155.
Migliori GB, D’Arcy M, Sotgiu G, Lange C. Multidrug-resistant and extensively drug-resistant tuberculosis in the West. Europe and United States: epidemiology, surveillance, and control. Clinics in chest medicine. 2009;30(4):637-665.
Prasad R. Multidrug and extensively drug-resistant tuberculosis management: Evidences and controversies. Lung India. 2012;29(2):154-159.
Bernal E, Munoz A, Nunez ML, Cano A. Multidrug-resistant spinal tuberculosis and giant paraspinal abscesses. Med Clin. 2012;138(4):184.
Kritski AL. Multidrug-resistant tuberculosis emergence: a renewed challenge. J braspneumol. 2010;36(2):157-158.
Ferro BE, Nieto LM, Rozo JC, Forero L, van Soolingen D. Multidrug-resistant Mycobacterium tuberculosis, Southwestern Colombia. EmergInfect Dis . 2011;17(7):1259-1262.
Imperiale BR, Zumarraga MJ, Weltman G, Zudiker R, Cataldi AA, Morcillo NS. First evaluation in Argentina of the GenoType(R) MTBDRplus assay for multidrug-resistant Mycobacterium tuberculosis detection from clinical isolates and specimens. Rev Argent Microbiol. 2012;44(4):283-289.
Martínez-Guarneros A, Rastogi N, Couvin D, Escobar-Gutiérrez A, Rossi LM, Vázquez-Chacón CA, et al. Genetic diversity among multidrug-resistant mycobacterium tuberculosis strains in Mexico. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases. 2013;14:434-443.
Kalokhe AS, Shafiq M, Lee JC, Ray SM, Wang YF, Metchock B, et al. Multidrug-resistant tuberculosis drug susceptibility and molecular diagnostic testing. The American Journal of the Medical Sciences. 2013;345(2):143-148.
Palmero DJ, Ambroggi M, Brea A, De Lucas M, Fulgenzi A, Martínez D, et al. Treatment and follow-up of HIV-negative multidrug-resistant tuberculosis patients in an infectious diseases reference hospital, Buenos Aires, Argentina. The international journal of tuberculosis and lung disease 2004; 8(6): 778-784.
Mitnick CD, Franke MF, Rich ML, Alcantara Viru FA, Appleton SC, Atwood SS, et al. Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality. PloS one. 2013;8(3):e58664.
Torralba-González M, Méndez R, Guerra A, Rodríguez M. Protocolo terapéutico de la tuberculosis multirresistente. Medicine. 2010; 10(56): 3856-3859.
Fortún J, Martín-Dávila P, Rodríguez JM, Navas E, Moreno S. Infección por Mycobacterium tuberculosis. Medicine. 2010; 10(56): 3808-3819.
Wilson M. Recent Advances in the Laboratory Detection of Mycobacterium tuberculosis Complex and Drug Resistance. Clinical Infectious Diseases. 2011;52(11):1350-1355
Pelly T, Moore D, Gilman R, Evans C. Recent tuberculosis advances in Latin America. Current Opinion in Infectious Diseases 2004,17:397-403
Chan E, Iseman M. Multidrug-resistant and extensively drug-resistant tuberculosis: a review. Current Opinion in Infectious Diseases. 2008,21:587–595.
LoBue P. Extensively drug-resistant tuberculosis. Current Opinion in Infectious Diseases. 2009, 22:167–173
Nyendak M, Lewinsohn D, Lewinsohn D. New diagnostic methods for tuberculosis. Current Opinion in Infectious Diseases. 2009,22:174–182
Migliori GB, D’Arcy Richardson M, Sotgiu G, Lange C. Multidrug-resistant and extensively drug- resistant tuberculosis in the west Europe and United States: epidemiology, surveillance and control. Clin Chest Med. 2009; 30:637–665.
Navas E, Moreno S. Tuberculosis multirresistente y extremadamente resistente. Rev EspSanidPenit. 2010;12:91-98
Sánchez F, López J, Villarino E, Grosset J. New drugs for tuberculosis treatment. EnfermInfeccMicrobiolClin. 2011; 29 (Supl 1): 47-56.
Citado por
